Microbot Medical
MBOT
36 hedge funds and large institutions have $8.18M invested in Microbot Medical in 2014 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
100% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 7
9% more funds holding
Funds holding: 33 → 36 (+3)
1% more capital invested
Capital invested by funds: $8.11M → $8.18M (+$68K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$600K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$344K |
| 3 |
BCM
Bourgeon Capital Management
Darien,
Connecticut
|
+$175K |
| 4 |
Morgan Stanley
New York
|
+$124K |
| 5 |
Jane Street
New York
|
+$81.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.04M |
| 2 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
-$811K |
| 3 |
IHM
Iguana Healthcare Management
New York
|
-$222K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$47.8K |
| 5 |
D.E. Shaw & Co
New York
|
-$28.7K |
MBOT Hedge Fund Activity: Q1 2014 in Review
36 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q1 2014, worth a combined $8.18M — up 0.84% from $8.11M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new MBOT positions and 2 closed out — a net gain of 3 holders — while 14 added to existing stakes and 7 trimmed.
The largest buyer was BlackRock Institutional Trust, adding an estimated $600K. The largest seller was Sabby Management, exiting entirely with an estimated $1.04M sold.
- 36 institutional investors held Microbot Medical (MBOT) as of Q1 2014, up from 33 in Q4 2013.
- Funds reported $8.18M of Microbot Medical stock for Q1 2014, up 0.84% quarter-over-quarter.
- 5 funds opened new Microbot Medical positions in Q1 2014 and 2 closed out, a net change of +3 holders.
- The largest Microbot Medical buyer in Q1 2014 was BlackRock Institutional Trust, an estimated $600K added.
- The largest Microbot Medical seller in Q1 2014 was Sabby Management, an estimated $1.04M sold.
Based on aggregated 13F filings for Q1 2014.